Research AppraisalSystematic Review

Comparative Efficacy of Nutraceuticals on Endothelial Function: A Systematic Review and Network Meta-Analysis

Current atherosclerosis reportsNorouzzadeh, Mostafa, Rashedi, Minoo Hasan, Mahdavi-Mazdeh, Ghazaleh et al.12 June 2026DOI

Clinical Snapshot

60CEBM
Evidence: ModerateSystematic Review

PICO Framework

P — PopulationIndividuals with cardiovascular diseases (CVDs) and hypertension
I — InterventionDietary interventions/nutraceuticals (magnesium, vitamin D3, flaxseed, barberry, folic acid, omega-3)
C — ComparatorPlacebo or control interventions (network comparison)
O — OutcomesFlow-mediated dilation (FMD) as a measure of endothelial function

Bottom Line

This network meta-analysis suggests magnesium and vitamin D3 supplementation may provide clinically meaningful improvements in endothelial function (FMD) in patients with cardiovascular disease or hypertension, with high certainty evidence. However, the analysis relies on surrogate endpoints rather than hard clinical outcomes. While these findings support the potential role of targeted nutraceutical interventions as adjunct therapy for vascular health, the mixed certainty of evidence across different supplements and lack of long-term clinical outcome data limit immediate practice recommendations. Clinicians should consider these interventions within established cardiovascular risk management frameworks, particularly for patients with documented endothelial dysfunction, while awaiting trials with clinical endpoints.

Evidence: Moderate

Key Findings

  • P Value: Not reported

  • Effect Size: Magnesium: MD 8.17; Vitamin D3: MD 7.84; Flaxseed: MD 7.39

  • Primary Outcome: Flow-mediated dilation (FMD) improvement

  • Nnt Or Sensitivity: Certainty of evidence: High (magnesium, vitamin D3), Moderate (barberry), Low (flaxseed, folic acid), Very low (omega-3)

  • Confidence Interval: Not reported in abstract

Clinical Application

High feasibility as interventions are readily available nutraceuticals, though optimal dosing and duration unclear Relevant to Australian practice; magnesium and vitamin D3 available on PBS for specific indications; aligns with RACGP cardiovascular risk management guidelines emphasising lifestyle interventions Adults with established cardiovascular disease or hypertension requiring adjunct vascular protection strategies

Abstract

PURPOSE OF REVIEW: This network meta-analysis (NMA) compares the efficacy of dietary interventions in improving flow mediated dilation (FMD) as a measure of endothelial function among individuals with cardiovascular diseases (CVDs) and hypertension. This work can be a basis for the design of future clinical trials and for the development of evidence-based nutritional guidelines to improve cardiovascular outcomes. RECENT FINDINGS: The most substantial improvements in FMD were observed with magnesium (MD: 8.17; CoE: High), vitamin D3 (MD: 7.84; CoE: High), flaxseed (MD: 7.39; CoE: Low), barberry (MD: 6.64; CoE: Moderate), folic acid (MD: 3.36; CoE: Low), and omega-3 (MD: 1.83; CoE: Very low). Sensitivity analyses confirmed the robustness of these findings. Several dietary interventions, particularly magnesium and vitamin D₃, have been shown to improve endothelial function in individuals with CVDs and hypertension. These findings highlight the potential role of nutritional strategies as adjunct therapies for preserving vascular health. TRIAL REGISTRATION: Systematic review registered with PROSPERO, registration number CRD420251041093.

References

  1. 1.Norouzzadeh, M., Rashedi, M. H., Mahdavi-Mazdeh, G., Kosari, A., & Shahinfar, H. (2026). Comparative efficacy of nutraceuticals on endothelial function: A systematic review and network meta-analysis. Current Atherosclerosis Reports. https://doi.org/10.1007/s12603-013-0043-6
Share:XLinkedIn

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service